https://www.selleckchem.com/MEK.html
Further research is necessary to investigate the potential of diverging therapeutic approaches.This study is a retrospective analysis using data collected from the Adelphi Paediatric Psoriasis Disease-Specific Programme cross-sectional survey. Despite being treated for their psoriasis, a substantial proportion of paediatric patients presented with moderate (18.3%) or severe (1.3%) disease at sampling; 42.9% and 92.0% had a body surface area (BSA) of 10%, and 38.8% and 100.0% had a Psoriasis Area Severity Index (PASI) score 10, respectively.